Literature DB >> 12162445

Roles of ferritin and iron in ischemic preconditioning of the heart.

Eduard Berenshtein1, Boris Vaisman, Chaya Goldberg-Langerman, Nahum Kitrossky, Abraham M Konijn, Mordechai Chevion.   

Abstract

Iron and copper play major roles in biological systems, catalyzing free radical production and consequently causing damage. The relatively high levels of these metals, which are mobilized into the coronary flow following prolonged ischemia, have been incriminated as key players in reperfusion injury to the heart. In the present communication we investigated other roles of iron - providing protection to the ischemic heart via preconditioning (PC). PC was accomplished by subjecting isolated rat hearts to three episodes of 2 min ischemia separated by 3 min of reperfusion. Prolonged ischemia followed the PC phase. PC hearts (group I) were compared to hearts subjected to normal perfusion (group II, no ischemia) and to ischemia without PC (group III). Group I showed a marked improvement in the recovery of hemodynamic function vs. group III. Biochemical parameters further substantiated the PC protection provided to group I against prolonged ischemia. Correspondingly, group I presented markedly lower re-distribution and mobilization of iron and copper into the coronary flow, following prolonged ischemia, as evinced from the decrease in total levels, and in the 'free' fraction of iron and copper. During the PC phase no loss of cardiac function was observed. A small wave of re-distribution and mobilization of iron (typically less than 4-8% of the value of 35 min ischemia) was recorded. The cellular content of ferritin (Ft) measured in the heart was significantly higher in group I than in group III (0.90 and 0.54 microg/mg, respectively). Also, iron-saturation of Ft was significantly lower for PC hearts, compared to both groups II and III (0.22 vs. 0.32 and 0.31 microg/mg, for 35 min ischemia, respectively). These findings are in accord with the proposal that intracellular re-distribution and mobilization of small levels of iron, during PC, cause rapid accumulation of ferritin - the major iron-storage protein. It is proposed that iron play a dual role: (i) It serves as a signaling pathway for the accumulation of Ft following the PC phase. This iron is not involved in cardiac injury, but rather prepares the heart against future high levels of 'free' iron, thus reducing the degree of myocardial damage after prolonged ischemia. (ii) High levels of iron (and copper) are mobilized following prolonged ischemia and cause tissue damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162445

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

1.  Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors.

Authors:  B Vaisman; E Fibach; A M Konijn
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts.

Authors:  G Ambrosio; J T Flaherty; C Duilio; I Tritto; G Santoro; P P Elia; M Condorelli; M Chiariello
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Cardiac reperfusion damage prevented by a nitroxide free radical.

Authors:  D Gelvan; P Saltman; S R Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction.

Authors:  Y Cottin; J M Doise; V Maupoil; M Tannière-Zeller; F Dalloz; M Maynadié; M K Walker; P Louis; P M Carli; J E Wolf; L Rochette
Journal:  Fundam Clin Pharmacol       Date:  1998       Impact factor: 2.748

5.  Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis.

Authors:  R T Rowland; X Meng; J C Cleveland; D R Meldrum; A H Harken; J M Brown
Journal:  J Surg Res       Date:  1997-08       Impact factor: 2.192

Review 6.  Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation.

Authors:  B Halliwell; M Grootveld; J M Gutteridge
Journal:  Methods Biochem Anal       Date:  1988

7.  Menadione mimics the infarct-limiting effect of preconditioning in isolated rat hearts.

Authors:  Y Yue; M Krenz; M V Cohen; J M Downey; S D Critz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-08       Impact factor: 4.733

8.  Superoxide-mediated release of iron from ferritin by some flavoenzymes.

Authors:  Y Bando; K Aki
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

9.  The cellular labile iron pool and intracellular ferritin in K562 cells.

Authors:  A M Konijn; H Glickstein; B Vaisman; E G Meyron-Holtz; I N Slotki; Z I Cabantchik
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

10.  Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart.

Authors:  E Karwatowska-Prokopczuk; E Czarnowska; A Beresewicz
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

View more
  20 in total

1.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Aging is an organ-specific process: changes in homeostasis of iron and redox proteins in the rat.

Authors:  Baruch E Bulvik; Eduard Berenshtein; Abraham Marim Konijn; Leonid Grinberg; Vladimir Vinokur; Ron Eliashar; Mordechai Mottie Chevion
Journal:  Age (Dordr)       Date:  2011-06-04

3.  Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2.

Authors:  Hong-Lin Zhu; Xing Wei; Shun-Lin Qu; Chi Zhang; Xiao-Xia Zuo; Yan-Sheng Feng; Qi Luo; Guang-Wen Chen; Mei-Dong Liu; Lei Jiang; Xian-Zhong Xiao; Kang-Kai Wang
Journal:  Exp Mol Med       Date:  2011-08-31       Impact factor: 8.718

4.  Molecular analysis of increased iron status in moderately exercised rats.

Authors:  Yu Qian Liu; Xiang Lin Duan; Yan Zhong Chang; Hai Tao Wang; Zhong Ming Qian
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

5.  Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene.

Authors:  Masayo Naito; Karol Bomsztyk; Richard A Zager
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

6.  d-Propranolol protects against oxidative stress and progressive cardiac dysfunction in iron overloaded rats.

Authors:  Jay H Kramer; Christopher F Spurney; Micaela Iantorno; Constantine Tziros; Joanna J Chmielinska; I Tong Mak; William B Weglicki
Journal:  Can J Physiol Pharmacol       Date:  2012-08-22       Impact factor: 2.273

7.  Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress.

Authors:  Tomáš Filipský; Michal Říha; Pavlína Hašková; Veronika Pilařová; Lucie Nováková; Vladimír Semecký; Jaroslava Vávrová; Magdaléna Holečková; Vladimir Palicka; Tomáš Šimůnek; Radomír Hrdina; Přemysl Mladěnka
Journal:  Redox Rep       Date:  2016-03-21       Impact factor: 4.412

Review 8.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.

Authors:  José Lillo-Moya; Catalina Rojas-Solé; Diego Muñoz-Salamanca; Emiliano Panieri; Luciano Saso; Ramón Rodrigo
Journal:  Antioxidants (Basel)       Date:  2021-04-25

9.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

10.  Cardiac protection by preconditioning is generated via an iron-signal created by proteasomal degradation of iron proteins.

Authors:  Baruch E Bulvik; Eduard Berenshtein; Esther G Meyron-Holtz; Abraham M Konijn; Mordechai Chevion
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.